United Kingdom
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 10.35 B
|
Dec. 31, 2023 | USD 140.24 | -0.22% |
|
United Kingdom |
|
2 |
USD 8.61 B
|
Dec. 31, 2023 | USD 17.39 | -0.08% |
|
United Kingdom |
|
3 |
USD 2.67 B
|
Dec. 31, 2023 | USD 4.67 | 0.65% |
|
United Kingdom |
|
4 |
USD 608.00 M
|
Dec. 31, 2023 | USD 12.79 | 0.04% |
|
United Kingdom |
|
5 |
USD 608.00 M
|
Dec. 31, 2023 | USD 28.38 | -0.06% |
|
United Kingdom |
|
6 |
USD 537.35 M
|
July 31, 2024 | USD 25.30 | -1.17% |
|
United Kingdom |
|
7 |
USD 485.78 M
|
March 31, 2024 | USD 37.51 | -0.51% |
|
United Kingdom |
|
8 |
USD 367.40 M
|
Dec. 31, 2023 | USD 3.02 | -1.33% |
|
United Kingdom |
|
9 |
USD 264.93 M
|
Sept. 30, 2024 | USD 56.22 | -0.33% |
|
United Kingdom |
|
10 |
USD 254.34 M
|
Dec. 31, 2023 | USD 2.89 | -0.48% |
|
United Kingdom |
|
11 |
USD 74.91 M
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
|
12 |
USD 39.96 M
|
Dec. 31, 2023 | USD 0.76 | 0.22% |
|
United Kingdom |
|
13 |
USD 35.64 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
14 |
USD 21.93 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
15 |
USD 11.88 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
16 |
USD 10.82 M
|
June 30, 2024 | USD 38.56 | 0.38% |
|
United Kingdom |
|
17 |
USD 8.03 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
18 |
USD 7.29 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
19 |
USD 2.94 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
20 |
USD 2.38 M
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
21 |
USD 725.55 K
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
22 |
USD -693.77 K
|
June 30, 2024 | USD 0.01 | -9.39% |
|
United Kingdom |
|
23 |
USD -837.81 K
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
24 |
USD -2.11 M
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
25 |
USD -2.18 M
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
26 |
USD -2.21 M
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
27 |
USD -2.23 M
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
28 |
USD -2.32 M
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
29 |
USD -2.71 M
|
May 31, 2024 | USD 0.24 | 1.95% |
|
United Kingdom |
|
30 |
USD -3.45 M
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
31 |
USD -4.77 M
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
32 |
USD -4.92 M
|
June 30, 2024 | USD 0.25 | 0.38% |
|
United Kingdom |
|
33 |
USD -6.25 M
|
March 31, 2024 | USD 1.69 | 0.00% |
|
United Kingdom |
|
34 |
USD -6.32 M
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
35 |
USD -7.16 M
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
36 |
USD -7.43 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
37 |
USD -7.60 M
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
38 |
USD -7.72 M
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
39 |
USD -7.77 M
|
Dec. 31, 2023 | USD 4.20 | -6.92% |
|
United Kingdom |
|
40 |
USD -7.86 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
41 |
USD -8.61 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
42 |
USD -9.49 M
|
March 31, 2024 | USD 1.06 | -3.64% |
|
United Kingdom |
|
43 |
USD -9.55 M
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
44 |
USD -10.46 M
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
45 |
USD -16.43 M
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
46 |
USD -18.40 M
|
Dec. 31, 2023 | USD 0.20 | -0.86% |
|
United Kingdom |
|
47 |
USD -18.92 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
|
48 |
USD -19.56 M
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
49 |
USD -21.13 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
50 |
USD -27.48 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Operating Cash Flow is AstraZeneca PLC (LSE: AZN.L) at USD 10.35 B.
The Healthcare company in United Kingdom with the lowest Operating Cash Flow is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD -765.27 M.
The top 10 Healthcare companies in United Kingdom by Operating Cash Flow are AstraZeneca PLC, GSK plc, Haleon plc, Smith & Nephew plc, Hikma Pharmaceuticals PLC, Smiths Group plc, Halma plc, ConvaTec Group Plc, Diploma PLC and Spire Healthcare Group plc.
The bottom 10 Healthcare companies in United Kingdom by Operating Cash Flow are Roivant Sciences Ltd., Centessa Pharmaceuticals plc, Autolus Therapeutics plc, COMPASS Pathways plc, Bicycle Therapeutics plc, Verona Pharma plc, Silence Therapeutics plc, Shield Therapeutics plc, Allergy Therapeutics plc and Oxford Biomedica plc.